title: Anti-interleukin-12 antibody treatment for Crohn disease: potential risk of invasive disease due to mycobacteria and salmonellae infection.
authors.forename: Calman
authors.initials: C
authors.lastname: MacLennan
authors.forename: David A
authors.initials: DA
authors.lastname: Lammas
authors.forename: Dinakantha S
authors.initials: DS
authors.lastname: Kumararatne
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D018664:Interleukin-12 / Q000276:immunology*; D009164:Mycobacterium Infections / Q000150:complications*; D012480:Salmonella Infections / Q000150:complications*
chemical_list: D000911:Antibodies, Monoclonal; D018664:Interleukin-12